A new collaboration with the International Natural Product Sciences Taskforce (INPST) explores the science behind natural products and promotes science communication [...]
The latest Frontiers in Pharmacology section promotes cutting-edge discoveries contributing to the goal of eliminating renal dialyses and deaths from kidney diseases. [...]
The article, on the role of adenosine receptors in Amyotrophic Lateral Sclerosis (or motor neuron disease), comes from scientists at the University of Lisbon, Portugal. [...]
Computer modelling suggests that drug combinations could protect from long-term drug level reductions in certain patients after a break from anti-cancer drug. [...]
Academic, pharmaceutical, healthcare policy and pension fund perspectives. — By Elliott Williams “The fundamental questions of whether aging can and should be [...]
Frontiers in Pharmacology was launched in 2010. In just 4 years, it has become the 3rd largest and the 2nd most cited open access journal in Pharmacology & [...]